| Literature DB >> 30065938 |
Ying Yu1,2, Qin Gao1,2, Wanning Xia3, Lina Zhang4, Zhiyuan Hu2, Xuesen Wu3, Xianjie Jia3.
Abstract
This study aimed to investigate the role of different types and frequencies of physical exercise in biomarkers of oxidative stress among middle-aged and elderly community residents with essential hypertension in China. A community-based cross-sectional survey was undertaken in 7 subdistricts. Individuals, 45-79 years old, with essential hypertension (n = 402) and without cardiovascular disease (n = 1047) were included. Superoxide dismutase (SOD) activities and plasma levels of malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE) were determined. Multilevel linear regression was used to estimate the associations between various types of physical exercise and oxidative stress biomarker levels. Participants engaged in high frequency walking/square dancing or taiji/yoga demonstrated decreased systolic blood pressure in both groups; however, diastolic blood pressure decreased only among individuals with hypertension participating in walking/square dancing. In individuals with hypertension, MDA levels decreased in those participating in walking/square dancing, SOD activity increased in those participating in walking/square dancing, and 4-HNE levels decreased in those involved in taiji/yoga. In individuals without cardiovascular disease, MDA levels decreased in those involved in walking/square dancing or taiji/yoga, SOD activity increased in those performing walking/square dancing, and 4-HNE levels decreased in those involved in taiji/yoga. Oxidative stress marker levels also improved in those involved in walking/square dancing or taiji/yoga groups as the exercise frequency increased. Thus, frequent participation in walking/square dancing or taiji/yoga effectively decreases hypertension-related oxidative stress biomarker levels.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30065938 PMCID: PMC6051290 DOI: 10.1155/2018/4135104
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Flowchart of participant selection process.
Demographics of the study participants.
| Variables | Individuals with hypertension ( | Individuals without CVD ( |
|
|
|---|---|---|---|---|
| Age, years | 63.82 ± 10.42 | 57.88 ± 10.90 | 9.39 | 0.001 |
| Men, n (%) | 192 (47.8) | 418 (39.9) | 7.32 | 0.007 |
| Years of Education | 2.04 | 0.361 | ||
| <9 years | 137(34.1%) | 326(31.1%) | ||
| 9-12 years | 233(58.0%) | 649(62.0%) | ||
| >12 years | 32(8.0%) | 72(6.9%) | ||
| Marital status | 8.71 | 0.033 | ||
| Married | 325(80.8%) | 899(85.9%) | ||
| Widower | 62(15.4%) | 104(9.9%) | ||
| Divorced | 15(3.7%) | 44(4.2%) | ||
| Income (RMB/month) | 4.69 | 0.196 | ||
| <2000 | 80(19.9%) | 161(15.4%) | ||
| 2000-3000 | 128(31.8%) | 357(34.1%) | ||
| 3000-4000 | 141(35.1%) | 372(35.5%) | ||
| >4000 | 53(13.2%) | 157(15.0%) | ||
| Smoking status, n (%) | 13.32 | 0.001 | ||
| No | 195(48.5%) | 873(83.4%) | ||
| Yes | 207(51.5%) | 174(16.6%) | ||
| Alcohol consumption, n (%) | 1.47 | 0.225 | ||
| No | 139(34.6%) | 398(38.0%) | ||
| Yes | 263(65.4%) | 649(62.0%) | ||
| Fruit consumption, n (%) | 11.86 | 0.001 | ||
| No | 139(34.6%) | 267(25.5%) | ||
| Yes | 263(65.4%) | 780(74.5%) | ||
Data are presented as mean ± SD.
Clinical characteristics of the study participants.
| Variables | Individuals with hypertension ( | Individuals without CVD ( |
|
|
|---|---|---|---|---|
| Age, years | 63.82 ± 10.42 | 57.88 ± 10.90 | 9.39 | 0.001 |
| Men, n (%) | 192 (47.8) | 418 (39.9) | 7.32 | 0.007 |
| BMI (kg/m2) | 25.72 ± 4.83 | 24.13 ± 3.68 | 6.47 | 0.001 |
| SBP (mmHg) | 141.02 ± 16.03 | 126.68 ± 17.46 | 14.87 | 0.001 |
| DBP (mmHg) | 81.03 ± 8.57 | 80.58 ± 9.42 | 1.15 | 0.249 |
| HR (beats/min) | 77.50 ± 7.35 | 72.52 ± 5.29 | 14.31 | 0.001 |
| HbA1c (%) | 5.31 ± 1.18 | 5.17 ± 1.15 | 2.02 | 0.044 |
| TC (mmol/L) | 5.13 ± 0.90 | 5.03 ± 0.97 | 1.78 | 0.076 |
| TG (mmol/L) | 1.95 ± 1.66 | 1.59 ± 1.33 | 4.40 | 0.001 |
| MDA (nmol/mL) | 5.59 ± 2.26 | 4.34 ± 1.64 | 10.13 | 0.001 |
| SOD (U/mL) | 35.69 ± 12.53 | 57.88 ± 16.86 | 27.26 | 0.001 |
| 4-HNE | 11.98 ± 2.31 | 9.83 ± 1.89 | 16.65 | 0.001 |
BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; HR: heart rate; HbA1c: glycosylated hemoglobin; TC: total cholesterol; TG: triglycerides; MDA: malondialdehyde; SOD: superoxide dismutase; 4-HNE: 4-hydroxynonenal. Data are presented as means ± SD.
Relationships between blood pressure and the five types of PE.
| Type of PE | Frequency | Individuals with hypertension ( | Individuals without CVD ( | ||
|---|---|---|---|---|---|
| SBP (mmHg) | DBP (mmHg) | SBP (mmHg) | DBP (mmHg) | ||
| PE1 | 0 days | 143.72 ± 14.98 | 83.83 ± 8.62 | 129.88 ± 17.58 | 81.18 ± 9.09 |
| 1-3 days | 141.15 ± 16.11 | 80.00 ± 7.85 | 126.17 ± 19.13 | 81.89 ± 7.84 | |
| 4-7 days | 139.70 ± 17.02 | 79.14 ± 8.55 | 126.24 ± 17.19 | 80.68±9.18 | |
| PE2 | 0 days | 145.36 ± 17.68 | 83.27 ± 12.21 | 129.22 ± 19.51 | 82.75 ± 9.90 |
| 1-3 days | 142.32 ± 15.10 | 83.03 ± 8.15 | 127.77 ± 17.29 | 80.88 ± 9.02 | |
| 4-7 days | 137.44 ± 11.31 | 81.00 ± 8.69 | 125.64 ± 14.96 | 80.48 ± 8.89 | |
| PE3 | 0 days | 128.01 ± 17.50 | 81.73 ± 8.94 | 142.84 ± 16.36 | 80.80 ± 8.99 |
| 1-3 days | 127.17 ± 17.76 | 80.46 ± 8.39 | 137.08 ± 13.94 | 81.77 ± 9.44 | |
| PE4 | 0 days | 141.79 ± 16.18 | 81.50 ± 8.91 | 127.70 ± 17.51 | 80.84 ± 8.9 |
| 1-3 days | 141.44 ± 15.31 | 81.44 ± 8.27 | 129.09 ± 17.84 | 81.89 ± 10.11 | |
| PE5 | 0 days | 144.48 ± 16.66 | 84.08 ± 10.42 | 128.02 ± 17.76 | 81.03 ± 8.94 |
| 1-3 days | 142.50 ± 19.67 | 83.90 ± 8.40 | 126.97 ± 15.72 | 80.22 ± 9.76 | |
| 4-7 days | 141.30 ± 15.91 | 81.25 ± 8.72 | 125.10 ± 16.39 | 81.75 ± 11.56 | |
PE: physical exercise; CVD: cardiovascular disease; SBP: systolic blood pressure; DBP: diastolic blood pressure; PE1: walking/square dancing; PE2: taiji/yoga; PE3: running/biking/climbing; PE4: ball sports; PE5: gym workout including swimming. Data are presented as means ± SD.
p < 0.05 versus 0 days.
Relationships between clinical characteristics and the five types of PE.
| Type of PE | Frequency | Individuals with hypertension ( | Individuals without CVD ( | ||||||
|---|---|---|---|---|---|---|---|---|---|
| BMI | HR | HbA1c | TG | BMI | HR | HbA1c | TG | ||
| PE1 | 0 days | 25.70 ± 4.19 | 77.56 ± 7.51 | 5.71 ± 1.41 | 2.02 ± 0.83 | 24.94 ± 2.79 | 72.75 ± 5.55 | 5.75 ± 1.08 | 1.53 ± 0.97 |
| 1-3 days | 25.65 ± 5.35 | 77.10 ± 6.06 | 5.29 ± 1.18 | 1.70 ± 0.81 | 23.57 ± 2.38 | 72.35 ± 4.75 | 5.23 ± 1.22 | 1.64 ± 1.07 | |
| 4-7 days | 25.19 ± 3.51 | 77.47 ± 7.33 | 5.09 ± 1.15 | 1.89 ± 0.72 | 22.19 ± 2.54 | 72.31 ± 5.11 | 4.35 ± 1.04 | 1.62 ± 1.59 | |
| PE2 | 0 days | 26.12 ± 3.39 | 79.13 ± 6.63 | 5.32 ± 1.22 | 2.06 ± 1.61 | 24.21 ± 4.07 | 72.45 ± 5.41 | 5.18 ± 1.15 | 1.60 ± 1.43 |
| 1-3 days | 25.59 ± 5.11 | 77.91 ± 7.33 | 5.43 ± 1.33 | 1.93 ± 1.65 | 23.99 ± 3.52 | 73.36 ± 4.59 | 5.11 ± 1.11 | 1.56 ± 0.60 | |
| 4-7 days | 24.82 ± 3.50 | 77.08 ± 7.47 | 5.21 ± 0.93 | 1.87 ± 0.95 | 23.62 ± 4.09 | 72.38 ± 4.94 | 5.16 ± 1.18 | 1.49 ± 0.91 | |
| PE3 | 0 days | 25.74 ± 4.91 | 77.31 ± 7.32 | 5.28 ± 1.16 | 1.99 ± 0.72 | 24.99 ± 2.68 | 73.01 ± 5.42 | 5.14 ± 1.13 | 1.61 ± 0.47 |
| 1-3 days | 25.22 ± 4.11 | 78.28 ± 7.43 | 5.44 ± 1.27 | 1.52 ± 0.75 | 22.02 ± 2.48 | 72.41 ± 5.26 | 5.31 ± 1.21 | 1.49 ± 0.44 | |
| PE4 | 0 days | 25.66 ± 4.79 | 77.66 ± 7.47 | 5.29 ± 1.15 | 1.97 ± 1.74 | 24.35 ± 3.83 | 72.45 ± 5.22 | 5.19 ± 1.16 | 1.59 ± 1.37 |
| 1-3 days | 25.53 ± 4.53 | 76.00 ± 5.89 | 5.51 ± 1.43 | 1.86 ± 1.26 | 23.95 ± 3.62 | 72.95 ± 5.78 | 5.01 ± 1.02 | 1.51 ± 0.88 | |
| PE5 | 0 days | 26.10 ± 3.81 | 77.64 ± 7.32 | 5.31 ± 1.18 | 1.92 ± 1.65 | 24.12 ± 3.24 | 72.52 ± 5.22 | 5.17 ± 1.15 | 1.60 ± 1.38 |
| 1-3 days | 25.63 ± 4.82 | 76.04 ± 7.85 | 5.30 ± 1.25 | 2.20 ± 1.81 | 24.06 ± 3.69 | 72.42 ± 5.70 | 5.18 ± 1.16 | 1.41 ± 0.80 | |
| 4-7 days | 25.73 ± 4.90 | 75.80 ± 6.92 | 5.27 ± 0.79 | 2.25 ± 1.36 | 23.35 ± 3.26 | 72.50 ± 6.56 | 5.41 ± 1.28 | 1.56 ± 0.57 | |
PE: physical exercise; CVD: cardiovascular disease; BMI: body mass index; HR: heart rate; HbA1c: glycosylated hemoglobin; TG: triglycerides; PE1: walking/square dancing; PE2: taiji/yoga; PE3: running/biking/climbing; PE4: ball sports; PE5: gym workout including swimming. Data are presented as means ± SD.
p < 0.05 versus 0 days.
Figure 2Relationships between the five types of PE and oxidative stress markers MDA: malondialdehyde; SOD: superoxide dismutase; 4-HNE: 4-hydroxynonenal; PE1: walking/square dancing; PE2: taiji/yoga; PE3: running/biking/climbing; PE4: ball sports; PE5: gym workout including swimming. Data are presented as means ± SD. p < 0.05 versus 0 days, p < 0.01 versus 0 days; #p < 0.05 versus 4-7 days, ##p < 0.01 versus 4-7 days.
Multilevel linear regression on PE and oxidative stress markers.
| Variable | MDA | SOD | 4-HNE | |||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |
| Individuals with hypertension | ||||||
| PE1 | -0.461 | 0.001 | 2.385 | 0.001 | -0.234 | 0.075 |
| PE2 | -0.247 | 0.106 | -0.719 | 0.405 | -1.228 | 0.001 |
| PE3 | -0.193 | 0.511 | -1.700 | 0.306 | -0.287 | 0.352 |
| PE4 | -0.200 | 0.619 | 1.087 | 0.633 | -0.268 | 0.526 |
| PE5 | 0.152 | 0.262 | 0.443 | 0.798 | 0.293 | 0.363 |
| Individuals without CVD | ||||||
| PE1 | -0.461 | 0.001 | 2.269 | 0.001 | -0.030 | 0.648 |
| PE2 | -0.501 | 0.001 | -1.222 | 0.131 | -0.563 | 0.001 |
| PE3 | -0.007 | 0.959 | 2.088 | 0.012 | 0.129 | 0.428 |
| PE4 | 0.218 | 0.195 | -1.603 | 0.366 | -0.246 | 0.215 |
| PE5 | -0.615 | 0.045 | 0.827 | 0.563 | -0.092 | 0.564 |
MDA: malondialdehyde; SOD: superoxide dismutase; 4-HNE: 4-hydroxynonenal; PE1: walking/square dancing; PE2: taiji/yoga; PE3: running/biking/climbing; PE4: ball sports; PE5: gym workout including swimming.
β:regression coefficient.